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INTRODUCTION
Shwachman-Diamond syndrome (SDS) a rare autoso-
mal recessive disorder described first time 1964 (1), is
characterized by the association of exocrine pancreatic
and bone marrow dysfunction. Other systemic findings
(skeletal, liver and psychomotor) or problems secondary
to bone marrow dysfunction may also be detected (1–4).
Intermittent or persistent neutropenia is the most com-
mon hematologic finding, but anemia and thrombocyto-
penia are present in approximately 40% of the patients
(1–4).
In 2002, fine mapping identified the locus for SDS in
band 7q11. More recently Boocock et al. (5) identified 18
positional candidate genes in this locus and examined
eight of them for occurrence SDS-associated changes.
They found alterations only in a previously uncharac-
terised gene. This gene, designated SBDS (Shwachman-
Bodian-Diamond syndrome), is composed of five exons
spanning 7.9Kb. The authors also described a pseudogene
(SBDSP) with 97% homology to SBDS (5).
Only two reports have described mutations in the SBDS
gene. The original article described 14 different muta-
tions found in 158 SDS families, mostly of European
ancestry. The majority of SBDS mutations were found to
occur within a 240-bp region around exon 2 and resulted
from gene conversion as the result of recombination with
the pseudogene (5). In the other report, mutations were
identified in four patients; two recurring mutations and
three novel changes were found (6).
We describe a Portuguese patient with SDS found to
be compound heterozygous for two previously described
mutations (183–184TA.CT + 201A.G and 258+2T.C).
CASE REPORT
A 3-year-old boy presented with failure to thrive,
diarrhea, developmental delay and neutropenia. His peri-
natal history was uneventful. During his third month of
life the child was evaluated because of failure to thrive,
anaemia and hypotonia. A diagnosis of cytomegalovirus
infection was established. During his first 3 years inter-
mittent neutropenia was documented, with values ranging
from normal to severe (200 3 109/L). Initially increased
values of aspartate and alanine aminotransferases later
normalized, as did other liver function test values, in-
cluding a normal serum bilirubin, g-glutamyl transferase
and alkaline phosphatase. Clotting studies were normal.
At the time of his referral, height and weight below the
fifth percentile was noted with no dysmorphic features.
Laboratory investigations included hemoglobin of
10.5 g/dL and a white blood cell count of 4700/mm3
with a neutrophil count of 1645/mm3 and a platelet count
of 216000/mm3. Liver function tests were normal, as was
the chloride sweat test. A 72-hour fecal fat collection
revealed an abnormally increased fat loss. The fecal elas-
tase level was 15.9 mg/g (normal.200 mg/g), consistent
with pancreatic failure. The hemoglobin F level was elevated
for his age (2.76%) and defective neutrophil mobility
was observed (0.3 mm; normal range, 1.23–1.77). Bone
marrow aspirate with direct metaphase karyotype study
was normal. The skeletal survey revealed a metaphyseal
chondrodysplasia of the left hip and rib flaring.
Normal growth rate was re-established at the age of
4 years after institution of pancreatic enzyme supple-
mentation, and his height and weight attained the 25th
percentiles.
Molecular analysis of the SBDS gene, after parental
consent, was performed by direct sequencing of exon 2,
using the primers SBDSEX2F: 5#CTGAGGTTACAGT-
GACCCGAGA and SBDSEX2R: 5#CTTTCCTCCAGA-
AAAACAGCCT. Results revealed the presence of
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two previously described mutations, namely 183–
184TA.CT and 258+2T.C (Fig. 1). The nucleotides
of the polymorphisms 129–71G and 201A were found to
be A and G, respectively. To determine whether the two
mutations were allelic, polymerase chain reaction single-
strand conformational analysis was performed. After
electrophoresis on 8% acrylamide gels, the separated bands
were excised, purified and re-amplified for subsequent
sequencing in both directions, using the same forward
and reverse primers in independent sequencing reactions.
The 183–184TA.CT mutation and 201A.G polymor-
phism were found to be present in one of the alleles and
the 258+2T.C mutation and the 129–71G.A poly-
morphism were present in the other. Direct sequencing of
the pseudogene copy was also performed, using the same
SBDS forward primer (SBDSEX2F) and the specific
SBDSP primer SBDSPEX2R: 5#CGGACGTTGCAGT-
GAGCC (Fig. 1).
DISCUSSION
A wide spectrum of phenotypic abnormalities has been
described among patients with SDS (2–4). In the child
reported here, the diagnosis of SDS was made on the
basis of pancreatic dysfunction and hematological abnor-
malities (intermittent neutropenia and anaemia) found in
virtually all SDS patients, but also in light of an inap-
propriate height and weight, skeletal abnormalities and
reduction of neutrophil chemotaxis.
SDS is a rare and heterogeneous disorder, which raises
difficulties in its diagnosis in some patients. The presence
of a hot spot region in exon 2 of the SBDS gene was an
important finding in terms of facilitating diagnosis. In fact,
direct sequencing of this exon has enabled the detection of
mutations, in at least one of the alleles, in approximately
89% of SDS patients (5). These mutations are the result of
conversion events between SBDSP and SBDS (5).
Before recognizing the involvement of SBDS, geno-
type-phenotype correlations could only be inferred on the
basis of clinical manifestations (4). Concordance be-
tween affected siblings, presumed to have the same
genotype, was found only in terms of pancreatic disease
expression, providing very little evidence of genotype-
phenotype correlation. The identification of the SBDS
gene and mutations related with SDS will likely improve
our understanding of the observed spectrum of disease
phenotypes. Only one previous report (7) tentatively cor-
related the SBDS mutations with the nature, frequency
and age-related changes of the radiographic skeletal ab-
normalities. The authors found no correlation between
the genotype and the skeletal phenotype.
Detailed descriptions of the clinical profiles of SDS
patients with the corresponding genotypes, as in the
present report, could be important in establishing a more
global genotype-phenotype correlation or provide steps
towards the identification of other factors involved in the
disease manifestation.
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FIG. 1. Direct sequence chromatograms of exon 2 of SBDS and
SBDSP. Normal sequence of exon 2 of SBDSP (A) and SBDS
(B). Patient sequence revealing the presence of two mutations
and one polymorphism in SBDS (C). Patient sequence of one of
the bands obtained by polymerase chain reaction single-strand
conformational analysis, revealing the presence of the
258+2T.C mutation and absence of 183–184TA.CT mutation
and absence of 201A.G polymorphism (D).
116 LIMA ET AL.
J Pediatr Gastroenterol Nutr, Vol. 41, No. 1, July 2005
